Deinococcus radiodurans R1 Lysate Induces Tolerogenic Maturation in Lipopolysaccharide-Stimulated Dendritic Cells and Protects Dextran Sulfate Sodium-Induced Colitis in Mice
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Deinococcus radiodurans is an extremophilic bacterium that can thrive in harsh environments. This property can be attributed to its unique metabolites that possess strong antioxidants and other pharmacological properties. To determine the potential of D. radiodurans R1 lysate (DeinoLys) as a pharmacological candidate for inflammatory bowel disease (IBD), we investigated the antiinflammatory activity of DeinoLys in bone marrow-derived dendritic cells (BMDCs) and a colitis mice model. Lipopolysaccharide (LPS)-stimulated BMDCs treated with DeinoLys exhibited alterations in their phenotypic and functional properties by changing into tolerogenic DCs, including strongly inhibited proinflammatory cytokines (TNF-α and IL-12p70) and surface molecule expression and activated DC-induced T cell proliferation/activation with high IL-10 production. These phenotypic and functional changes in BMDCs induced by DeinoLys in the presence of LPS were abrogated by IL- 10 neutralization. Furthermore, oral administration of DeinoLys significantly reduced clinical symptoms against dextran sulfate sodium-induced colitis, including body weight loss, disease activity index, histological severity in colon tissue, and lower myeloperoxidase level in mice. Our results establish DeinoLys as a potential anti-inflammatory candidate for IBD therapy.
Abstract
Deinococcus radiodurans is an extremophilic bacterium that can thrive in harsh environments. This property can be attributed to its unique metabolites that possess strong antioxidants and other pharmacological properties. To determine the potential of D. radiodurans R1 lysate (DeinoLys) as a pharmacological candidate for inflammatory bowel disease (IBD), we investigated the antiinflammatory activity of DeinoLys in bone marrow-derived dendritic cells (BMDCs) and a colitis mice model. Lipopolysaccharide (LPS)-stimulated BMDCs treated with DeinoLys exhibited alterations in their phenotypic and functional properties by changing into tolerogenic DCs, including strongly inhibited proinflammatory cytokines (TNF-α and IL-12p70) and surface molecule expression and activated DC-induced T cell proliferation/activation with high IL-10 production. These phenotypic and functional changes in BMDCs induced by DeinoLys in the presence of LPS were abrogated by IL- 10 neutralization. Furthermore, oral administration of DeinoLys significantly reduced clinical symptoms against dextran sulfate sodium-induced colitis, including body weight loss, disease activity index, histological severity in colon tissue, and lower myeloperoxidase level in mice. Our results establish DeinoLys as a potential anti-inflammatory candidate for IBD therapy.
참고문헌 (36)
- Merino N, "Living at the extremes : extremophiles and the limits of life in a planetary context", Front. Microbiol, 10, pp.780~ (2019)
- Daletos G, "Natural products from deep-sea-derived fungi a new source of novel bioactive compounds?", Curr. Med. Chem, 25, pp.186~207 (2018)
- Gabani P, "Radiation-resistant extremophiles and their potential in biotechnology and therapeutics", Appl. Microbiol. Biotechnol, 97, pp.993~1004 (2013)
- Cox MM, "Deinococcus radiodurans-the consummate survivor", Nat. Rev. Microbiol, 3, pp.882~892 (2005)
- Slade D, "Oxidative stress resistance in Deinococcus radiodurans", Microbiol. Mol. Biol. Rev, 75, pp.133~191 (2011)
- Maqbool I, "Crude cell-free extract from Deinococcus radiodurans exhibit anticancer activity by inducing apoptosis in triple-negative breast cancer cells", Front. Cell Dev. Biol, 8, pp.707~ (2020)
- Choi YJ, "Induction of apoptosis by deinoxanthin in human cancer cells", Anticancer Res, 34, pp.1829~1835 (2014)
- Lin SM, "Antioxidant activities of an exopolysaccharide(DeinoPol)produced by the extreme radiation-resistant bacterium Deinococcus radiodurans", Sci. Rep, 10, pp.55~ (2020)
- Xiao TS, "Innate immunity and inflammation", Cell Mol. Immunol, 14, pp.1~3 (2017)
- Agrawal A, "Role of dendritic cells in inflammation and loss of tolerance in the elderly", Front. Immunol, 8, pp.896~ (2017)
- Audiger C, "The importance of dendritic cells in maintaining immune tolerance", J. Immunol, 198, pp.2223~2231 (2017)
- 유승보, "Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications", Immune Network, 16(1), pp.52~60 (2016), 대한면역학회[DOI]
- Fucikova J, "Induction of tolerance and immunity by dendritic cells : mechanisms and clinical applications", Front. Immunol, 10, pp.2393~ (2019)
- Obregon C, "Update on dendritic cell-induced immunological and clinical tolerance", Front. Immunol, 8, pp.1514~ (2017)
- 김명겸, "The Aqueous Extract of Radio-Resistant Deinococcus actinosclerus BM2T Suppresses Lipopolysaccharide-Mediated Inflammation in RAW264.7 Cells", Journal of Microbiology and Biotechnology, 30(4), pp.583~590 (2020), 한국미생물·생명공학회[DOI]
- Matheu MP, "Generation of bone marrow derived murine dendritic cells for use in 2-photon imaging", J. Vis. Exp, 9, pp.773~ (2008)
- Song HY, "A hydroxyethyl derivative of chrysin exhibits antiinflammatory activity in dendritic cells and protective effects against dextran sodium salt-induced colitis in mice", Int. Immunopharmacol, 77, pp.105958~ (2019)
- Claudio Hidalgo-Cantabrana, "Effect of a Ropy Exopolysaccharide-Producing Bifidobacterium animalis subsp. lactis Strain Orally Administered on DSS-Induced Colitis Mice Model", Frontiers in Microbiology, 7 (2016), Frontiers Media SA[DOI]
- Meers GK, "Impaired resolution of DSS-induced colitis in mice lacking the glucocorticoid receptor in myeloid cells", PLoS One, 13, pp.e0190846~ (2018)
- Thomson AW, "Tolerogenic dendritic cells for autoimmune disease and transplantation", Ann. Rheum. Dis, 67(3), pp.90~96 (2008)
- Joffre O, "Inflammatory signals in dendritic cell activation and the induction of adaptive immunity", Immunol. Rev, 227, pp.234~247 (2009)
- Jenkins MK, "Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo", J. Exp. Med, 165, pp.302~319 (1987)
- Morante-Palacios O, "Tolerogenic dendritic cells in autoimmunity and inflammatory diseases", Trends Immunol, 42, pp.59~75 (2021)
- Comi M, "Interleukin-10-producing DC-10 is a unique tool to promote tolerance via antigen-specific T regulatory type 1 cells", Front. Immunol, 9, pp.682~ (2018)
- Taylor A, "IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1", J. Allergy Clin. Immunol, 120, pp.76~83 (2007)
- Huang H, "Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-", loFoxp3-effector T cells, 2010, pp.185, 5003~5010
- Frick JS, "Colitogenic and non-colitogenic commensal bacteria differentially trigger DC maturation and Th cell polarization : an important role for IL-6", Eur. J. Immunol, 36, pp.1537~1547 (2006)
- Volz T, "Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells", J. Invest. Dermatol, 134, pp.96~104 (2014)
- Mizoguchi A, "Animal models of inflammatory bowel disease", Prog. Mol. Biol. Transl. Sci, 105, pp.263~320 (2012)
- Jones-Hall YL, "Immunopathological characterization of selected mouse models of inflammatory bowel disease : comparison to human disease", Pathophysiology, 21, pp.267~288 (2014)
- Eichele DD, "Dextran sodium sulfate colitis murine model : an indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis", World J. Gastroenterol, 23, pp.6016~6029 (2017)
- Pedersen AE, "Dexamethasone", 1alpha-25-dihydroxyvitamin D3-treated dendritic cells suppress colitis in the SCID T-cell transfer model, 2009, pp.127, 354~364
- Kim WS, "Therapeutic potential of gamma-irradiated resveratrol in ulcerative colitis via the anti-inflammatory activity and differentiation of tolerogenic dendritic cells", Cell. Physiol. Biochem, 52, pp.1117~1138 (2019)
- Cabezon R, "Therapeutic potential of tolerogenic dendritic cells in IBD : from animal models to clinical application", Clin. Dev. Immunol, 2013, pp.789814~ (2013)
- Cardoso A, "The dynamics of interleukin-10-afforded protection during dextran sulfate sodium-induced colitis", Front. Immunol, 9, pp.400~ (2018)
- Zhang W, "Reduction of inflammatory bowel disease-induced tumor development in IL-10 knockout mice with soluble epoxide hydrolase gene deficiency", Mol. Carcinog, 52, pp.726~738 (2013)
